NCT04366713 2023-02-10A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With NeratinibPuma Biotechnology, Inc.Phase 2 Completed6 enrolled 8 charts
NCT00401388 2018-03-07A Trial of Perifosine in Patients With Chemo-Insensitive SarcomasAEterna ZentarisPhase 2 Completed72 enrolled